Masimo Total Long-Term Assets 2010-2024 | MASI
Masimo total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
- Masimo total long-term assets for the quarter ending December 31, 2024 were $1.400B, a 22.64% decline year-over-year.
- Masimo total long-term assets for 2024 were $1.4B, a 22.64% decline from 2023.
- Masimo total long-term assets for 2023 were $1.81B, a 4.86% decline from 2022.
- Masimo total long-term assets for 2022 were $1.902B, a 193.29% increase from 2021.
| Masimo Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $1,400 |
| 2023 | $1,810 |
| 2022 | $1,902 |
| 2021 | $649 |
| 2020 | $611 |
| 2019 | $400 |
| 2018 | $366 |
| 2017 | $346 |
| 2016 | $313 |
| 2015 | $303 |
| 2014 | $268 |
| 2013 | $167 |
| 2012 | $155 |
| 2011 | $103 |
| 2010 | $93 |
| 2009 | $67 |
| Masimo Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,400 |
| 2024-09-30 | $1,808 |
| 2024-06-30 | $1,752 |
| 2024-03-31 | $1,792 |
| 2023-12-31 | $1,810 |
| 2023-09-30 | $1,758 |
| 2023-06-30 | $1,803 |
| 2023-03-31 | $1,855 |
| 2022-12-31 | $1,902 |
| 2022-09-30 | $1,811 |
| 2022-06-30 | $1,803 |
| 2022-03-31 | $684 |
| 2021-12-31 | $649 |
| 2021-09-30 | $629 |
| 2021-06-30 | $630 |
| 2021-03-31 | $615 |
| 2020-12-31 | $611 |
| 2020-09-30 | $554 |
| 2020-06-30 | $543 |
| 2020-03-31 | $494 |
| 2019-12-31 | $400 |
| 2019-09-30 | $380 |
| 2019-06-30 | $366 |
| 2019-03-31 | $329 |
| 2018-12-31 | $366 |
| 2018-09-30 | $360 |
| 2018-06-30 | $353 |
| 2018-03-31 | $353 |
| 2017-12-31 | $346 |
| 2017-09-30 | $360 |
| 2017-06-30 | $330 |
| 2017-03-31 | $321 |
| 2016-12-31 | $313 |
| 2016-09-30 | $315 |
| 2016-06-30 | $307 |
| 2016-03-31 | $304 |
| 2015-12-31 | $303 |
| 2015-09-30 | $280 |
| 2015-06-30 | $274 |
| 2015-03-31 | $260 |
| 2014-12-31 | $268 |
| 2014-09-30 | $233 |
| 2014-06-30 | $227 |
| 2014-03-31 | $172 |
| 2013-12-31 | $167 |
| 2013-09-30 | $166 |
| 2013-06-30 | $161 |
| 2013-03-31 | $159 |
| 2012-12-31 | $155 |
| 2012-09-30 | $149 |
| 2012-06-30 | $116 |
| 2012-03-31 | $114 |
| 2011-12-31 | $103 |
| 2011-09-30 | $97 |
| 2011-06-30 | $97 |
| 2011-03-31 | $96 |
| 2010-12-31 | $93 |
| 2010-09-30 | $79 |
| 2010-06-30 | $75 |
| 2010-03-31 | $70 |
| 2009-12-31 | $67 |
| 2009-09-30 | $61 |
| 2009-06-30 | $62 |
| 2009-03-31 | $62 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $8.993B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||